Search Results
Jul 03, 2026, 03:26 ET Los productos HiBy reciben varios galardones en el VGP SUMMER 2026
II: otorgadoHiBy R8 II: otorgadoHiBy Golden 10th Titanium Edition: otorgadoHiBy R6 Pro II 2025: otorgadoHiBy R6 III 2025: otorgadoHiBy R3 Pro II: otorgadoHiBy Digital M300: otorgadoHiBy ZETA II: otorgadoHiBy Digital YUME: otorgadoHiBy
More news about: HiBy
Jul 02, 2026, 18:47 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Insulet Corporation and Certain Officers - PODD
heightened risk that one or more Insulet products would be found to be in violation of applicable safety regulations and/or pose a risk of injury; and (iii) as a result, Defendants' public statements were materially false and misleading at all relevant times.The truth began to emerge on March 12,
More news about: Pomerantz LLP
Jul 02, 2026, 18:18 ET Kuehn Law Encourages Investors of Five9, Inc. to Contact Law Firm
challenging bookings quarter due, in part, to sales execution and efficiency issues, and the Company was not "seeing very strong bookings momentum"; and (iii) insiders did not have "enough information in terms of [their] existing customers that are going live" such that the statements that Five9 would see
More news about: Kuehn Law, PLLC
Jul 02, 2026, 18:05 ET CVLT INVESTOR DEADLINE: Commvault Systems, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
throughout fiscal year 2026; (ii) Commvault knew or recklessly disregarded the impact that different types of sales would have on its ARR growth; and (iii) the variation in net ARR growth is strongly based on the type of sale Commvault is making, thus, Commvault's projected net new ARR should not have been
More news about: Robbins Geller Rudman & Dowd LLP
Jul 02, 2026, 18:00 ET ORVANA PROVIDES TAGUAS DRILLING UPDATE: FULL ASSAY RESULTS FROM 2026 DRILLING CAMPAIGN; PROVIDES EL VALLE-BOINÁS BROWNFIELD DRILLING UPDATE
but is not limited to statements regarding: (i) the next steps of the Taguas exploration campaign; (ii) interpretation of a porphyry-related system; (iii) plans for the next drilling campaign; (iv) potential for copper-gold mineralization; and (v) geochronological study plans. Forward-looking information
More news about: Orvana Minerals Corp.
Jul 02, 2026, 17:26 ET Kuehn Law Encourages Investors of Dick's Sporting Goods, Inc. to Contact Law Firm
technology, and more efficient clearance channels, did not allow the Company to manage its excess inventory without hurting the Company's profitability; (iii) the need to liquidate excess inventory, including in the Outdoor segment, would have a materially negative effect on the Company's profitability; and
More news about: Kuehn Law, PLLC
Jul 02, 2026, 14:41 ET Northwest Biotherapeutics Announces Scientific Presentation on Propensity Score Matching at the British Neuro-Oncology Society Annual Meeting
(GBM). GBM is the most aggressive and lethal form of primary brain cancer, and is an "orphan disease." The Company has completed a 331-patient Phase III trial of DCVax-L for GBM, presented the results in scientific meetings, published the results in JAMA Oncology and submitted a MAA for commercial approval
More news about: Northwest Biotherapeutics, Inc.
Jul 02, 2026, 14:34 ET NNS acquiert des actions d'OCI
risques liés à l'obtention des autorisations réglementaires sans retards ni conditions imprévus, ainsi que la possibilité de mesures réglementaires ; (iii) les risques liés aux coûts importants associés à l'opération ; (iv) les performances financières et opérationnelles attendues ainsi que les opportunités
More news about: NNS Holding (Cyprus) Limited
Jul 02, 2026, 14:32 ET NNS erwirbt Anteile an OCI
im Zusammenhang mit dem Erhalt behördlicher Genehmigungen ohne unerwartete Verzögerungen oder Auflagen sowie die Möglichkeit behördlicher Maßnahmen; (iii) Risiken im Zusammenhang mit erheblichen Kosten der Transaktion; (iv) die erwartete finanzielle und operative Entwicklung sowie zukünftige Chancen nach
More news about: NNS Holding (Cyprus) Limited
Jul 02, 2026, 14:29 ET NNS adquiere acciones en OCI
riesgos relacionados con la obtención de aprobaciones regulatorias sin demoras o condiciones inesperadas y la posibilidad de acciones regulatorias; (iii) riesgos relacionados con costes significativos relacionados con la transacción; (iv) el rendimiento financiero y operativo esperado y las oportunidades
More news about: NNS Holding (Cyprus) Limited
Jul 02, 2026, 14:17 ET Northwest Biotherapeutics Announces Scientific Presentation on Propensity Score Matching at the British Neuro-Oncology Society Annual Meeting
(GBM). GBM is the most aggressive and lethal form of primary brain cancer, and is an "orphan disease." The Company has completed a 331-patient Phase III trial of DCVax-L for GBM, presented the results in scientific meetings, published the results in JAMA Oncology and submitted a MAA for commercial approval
More news about: Northwest Biotherapeutics, Inc.
Jul 02, 2026, 13:13 ET NNS acquires shares in OCI
at all; (ii) risks relating to the receipt of regulatory approvals without unexpected delays or conditions and the possibility of regulatory action; (iii) risks relating to significant costs related to the transaction; (iv) the expected financial and operating performance and future opportunities following
More news about: NNS Holding (Cyprus) Limited
Jul 02, 2026, 13:10 ET NNS acquires shares in OCI
at all; (ii) risks relating to the receipt of regulatory approvals without unexpected delays or conditions and the possibility of regulatory action; (iii) risks relating to significant costs related to the transaction; (iv) the expected financial and operating performance and future opportunities following
More news about: NNS Holding (Cyprus) Limited
Jul 02, 2026, 10:31 ET Non-Small Cell Lung Cancer Market Poised for Robust Expansion at a 6.6% CAGR Through 2036, Driven by Emerging Targeted and Immunotherapy Innovations | DelveInsight
therapeutic options for these patient populations.Despite remarkable progress in precision oncology and immunotherapy, early-stage NSCLC (Stages I–III) continues to represent a significant area of unmet need. Surgical resection followed by adjuvant platinum-based chemotherapy remains the standard of
More news about: DelveInsight Business Research, LLP
Jul 02, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GRAIL, Inc. of Class Action Lawsuit and Upcoming Deadlines - GRAL
information about joining the class action] On February 19, 2026, Grail announced that "primary endpoint of statistically significant Stage III-IV reduction was not observed" in the NHS-Galleri Trial. Grail attributed this shortcoming, in part, to "probably need[ing] a longer follow-up time
More news about: Pomerantz LLP
Jul 02, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Immutep Limited of Class Action Lawsuit and Upcoming Deadlines - IMMP
action] On March 13, 2026, Immutep issued a press release "announc[ing] that the Independent Data Monitoring Committee (IDMC) for the TACTI-004 Phase III study evaluating eftilagimod alfa ('efti') in patients in 1st line non-small cell lung cancer has recommended the discontinuation of the trial
More news about: Pomerantz LLP
Jul 02, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against First Solar, Inc. and Certain Officers - FSLR
and attempted relocation of production to the U.S., were likely to negatively impact First Solar's projected performance in the 2026 fiscal year; and (iii) as a result, Defendants' public statements were materially false and misleading at all relevant times.The truth began to emerge on January 7,
More news about: Pomerantz LLP
Jul 02, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Nano-X Imaging Ltd. and Certain Officers - NNOX
demand for its products; (ii) in reality, Nano-X's production and manufacturing operations were poorly aligned with demand for the Company's products; (iii) as a result, Nano-X was experiencing significantly increased operating expenses and cash burn; (iv) the foregoing significantly increased the likelihood
More news about: Pomerantz LLP
Jul 02, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Lucid Group, Inc . and Certain Officers - LCID
deliveries of the Lucid Gravity; (ii) the foregoing was likely to, and did, have a material negative impact on the Company's business and financial results; (iii) accordingly, the Defendants had overstated the purported enhancements to Lucid's manufacturing and delivery capabilities and overall operations; and
More news about: Pomerantz LLP
Jul 02, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against BitGo Holdings, Inc. and Certain Officers - BTGO
Defendants' statements regarding, inter alia, BitGo's financial performance and business prospects as a public company lacked a reasonable basis; and (iii) as a result, the Offering Documents and Defendants' public statements throughout the Class Period were materially false and/or misleading and/or failed
More news about: Pomerantz LLP
Jul 02, 2026, 10:00 ET Avanos Medical, Inc. and American Industrial Partners Receive Required Regulatory Approvals for Pending Merger
Such factors include: (i) uncertainties as to the timing of the acquisition, (ii) the possibility that competing acquisition proposals will be made; (iii) the possibility that Avanos will terminate the merger agreement to enter into an alternative transaction; (iv) the possibility that various closing
More news about: Avanos Medical
Jul 02, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against AeroVironment, Inc. and Certain Officers - AVAV
U.S. Space Force's ongoing efforts to modernize the SCN; (ii) accordingly, Defendants overstated AeroVironment's business and financial prospects; and (iii) as a result, Defendants' public statements were materially false and misleading at all relevant times.On January 20, 2026, AeroVironment announced
More news about: Pomerantz LLP
Jul 02, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Graphic Packaging Holding Company and Certain Former Officers - GPK
and severity of the foregoing issues, which were likely to, and did, have a material negative impact on the Company's business and financial results; (iii) Defendants likewise overstated the strength and sustainability of the Company's business model and operations, as well as its ability to weather ongoing
More news about: Pomerantz LLP
Jul 02, 2026, 09:28 ET GRAL SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Grail (GRAL) Investors of Securities Class Action Lawsuit Deadline on August 4, 2026
that the probability of achieving the statistical reduction in Stage III & IV cancers by the trial's end had been reduced.On February 19, 2026, Grail announced that the "primary endpoint of statistically significant Stage III-IV reduction was not observed" in the NHS-Galleri Trial. The Company
More news about: Faruqi & Faruqi, LLP
Jul 02, 2026, 09:15 ET Hagerty Agrees to Acquire Bennetts to Become #2 Specialty Motorcycle Insurance Broker in the United Kingdom
(i) that the acquisition may not be completed on the expected terms or timeline, or at all; (ii) that the closing conditions may not be satisfied; (iii) that the anticipated benefits of the acquisition may not be realized, including earnings enhancements and synergies; (iv) that Hagerty may be unable
More news about: Hagerty